Clinical Trial Update: Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating outpatient administration of high-dose methotrexate in patients with osteosarcoma has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• high-dose methotrexate (methotrexate)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Osteosarcoma | Phase 3 | Status: COMPLETED | Results posted: 2021-10-28